European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3
Standard
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3. / Panzuto, Francesco; Ramage, John; Pritchard, D Mark; van Velthuysen, Marie-Louise F; Schrader, Joerg; Begum, Nehara; Sundin, Anders; Falconi, Massimo; O'Toole, Dermot.
In: J NEUROENDOCRINOL, Vol. 35, No. 8, 08.2023, p. e13306.Research output: SCORING: Contribution to journal › Guideline, recommendation, statement › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3
AU - Panzuto, Francesco
AU - Ramage, John
AU - Pritchard, D Mark
AU - van Velthuysen, Marie-Louise F
AU - Schrader, Joerg
AU - Begum, Nehara
AU - Sundin, Anders
AU - Falconi, Massimo
AU - O'Toole, Dermot
N1 - © 2023 The Authors. Journal of Neuroendocrinology published by John Wiley & Sons Ltd on behalf of British Society for Neuroendocrinology.
PY - 2023/8
Y1 - 2023/8
N2 - The aim of the present guidance paper was to update the previous ENETS guidelines on well-differentiated gastric and duodenal neuroendocrine tumours (NETs), providing practical guidance for specialists in the diagnosis and management of gastroduodenal NETs. Type II gastric NETs, neuroendocrine carcinomas (NECs), and functioning duodenal NETs are not covered, since they will be discussed in other ENETS guidance papers.
AB - The aim of the present guidance paper was to update the previous ENETS guidelines on well-differentiated gastric and duodenal neuroendocrine tumours (NETs), providing practical guidance for specialists in the diagnosis and management of gastroduodenal NETs. Type II gastric NETs, neuroendocrine carcinomas (NECs), and functioning duodenal NETs are not covered, since they will be discussed in other ENETS guidance papers.
KW - Humans
KW - Neuroendocrine Tumors/diagnosis
KW - Stomach Neoplasms/diagnosis
KW - Societies
KW - Carcinoma, Neuroendocrine
U2 - 10.1111/jne.13306
DO - 10.1111/jne.13306
M3 - Guideline, recommendation, statement
C2 - 37401795
VL - 35
SP - e13306
JO - J NEUROENDOCRINOL
JF - J NEUROENDOCRINOL
SN - 0953-8194
IS - 8
ER -